| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Temozolomide | FAERS: 4 | OFFSIDES SIDER US FAERS | |
| 2 | Topotecan | FAERS: 4 | US FAERS | |
| 3 | Dasatinib | FAERS: 1 | US FAERS | |
| 4 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 5 | Isotretinoin | FAERS: 1 | US FAERS | |
| 6 | Lenalidomide | FAERS: 1 | US FAERS | |
| 7 | Norgestrel | FAERS: 1 | US FAERS | |
| 8 | Panobinostat | FAERS: 1 | US FAERS | |
| 9 | Thalidomide | FAERS: 1 | OFFSIDES US FAERS | |
| 10 | Valsartan | FAERS: 1 | US FAERS | |
| 11 | Vorinostat | FAERS: 1 | US FAERS | |
| 12 | Bisacodyl | OFFSIDES | ||
| 13 | Methylphenidate | OFFSIDES | ||
| 14 | Tretinoin | OFFSIDES | ||
| 15 | testosterone enanthate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.